Effects of aspirin and celecoxib on rigidity in a rat model of Parkinson's disease

Pakistan Journal of Biological Sciences

Volumn 10, Issue 21, 2007, Pages 3853-3858

  Moghaddam, Hadi Fathi ^a   Hemmati, Aliasghar ^a   Nazari, Zahra ^a   Mehrab, Hasan ^a   Abid, Khosro M ^b   Ardestani, Mehdi Shafiee ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aspirin; Celecoxib; Electrical lesion; Inflammation; NSAIDs; Parkinson's disease

Indexed keywords

ANIMALIA; PARKINSONIA; RATTUS;

EID: 36849013493     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2007.3853.3858     Document Type: Article

References (32)

1. Asanuma, M., I. Miyazaki, T. Tsuji and N. Ogawa, 2003. New aspects of neuroprotective effects of nonsteroidal anti-inflammatory drugs. Nihon Shinkei Seishin Yakurigaku Zasshi, 23: 111-119.
2. Bal-Price, A. and G.C. Brown, 2001. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci, 21: 6480-6491.
3. Banati, R.B., G.W. Goerres, R. Myers, R.N. Gunn, F.E. Turkheimer, G.W. Kreutzberg, D.J. Brooks, T. Jones and J.S. Duncan, 1999. [11C] (R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology, 53: 2199-2203.
4. Buccafusco, J.J., C.A. Lapp, R.S. Aronstam and A.C. Hays, 1993. Role of prostanoids in the regulation of central cholinergic receptor sensitivity. J. Pharmacol. Exp. Ther., 266: 314-322.
5. Casper, D., U. Yaparpalvi, N. Rempel and P. Wener, 2000. Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro. Neurosci. Lett., 289: 201-204.
6. Dubois, R.N., S.B. Abramson, L. Crofford and R.A. Cupta, 1998. Cyclooxygenase in biology and disease. FASEB J., 12: 1063-1073.
7. Etminan, M., S.S. Gill and A. Samii 2002. Intake of vitamin E, vitamin C and carotenoids and the risk of Parkinson's disease: A meta-analysis. Lancet Neurol., 4: 362-365.
8. Fahn, S. and S. Przedborski, 2000. In: Merritt's Neurology, Rowland, L.P. (Ed.). Inhibition of Cyclooxygenase-2 Protects Motor Neurons in an Organotypic Model of Amyotrophic Lateral Sclerosis. Ann. Neurol., 48: 792-795. Williams and Wilkins, Lippincott, New York, pp: 679-693.
9. Gao, H.M., J. Jiang, B. Wilson, W. Zhang, J.S. Hong and B. Liu, 2002. Microglial activation mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: Relevance to Parkinson's disease. J. Neurochem., 81: 1285-1297.
10. Herschman, H.R., 1996. Prostaglandin synthase-2. Biochem. Biophys. Acta, 1299: 153-179.
11. Hirsch, E.C., S. Hunot, P. Damier and B. Faucheux, 1998. Glial cells and inflammation in Parkinson's disease: A role in neurodegeneration. Ann. Neurol., 44: S115-120.
12. Ito, Y., 1982. Modulatory actions of prostaglandins in autonomic neuro-effector transmissions. Nippon Yakurigako Zasshi, 79: 1-14.
13. Katzung, B.G., 2004. Basic and Clinical Pharmacology. Williams and Wilkins, New York, pp: 298-311, 577.
14. King, D., J.R. Playfer and N.B. Roberts, 1992. Concentrations of vitamins A, C and E in elderly patients with Parkinson's disease. Postgrad. Med. J., 68: 634-637.
15. Li, R.C., B.W. Row, E. Gozal, Q. Fan and S.Z. Guo, 2003. Cyclooxygenase-2 and intermittent hypoxia-induced spatial defects in the rat. Am. J. Respir. Crit. Care Med., 168: 469-475.
16. McGeer, P.L. and E.G. McGeer, 2002. Innate immunity, local inflammation and degenerative disease. Sci. Aging Knowledge Environ., 29 Rev. 3.
17. McGeer, P.L., C. Schwab, A. Parent and D. Doudet, 2003. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine administration. Ann. Neurol., 54: 599-604.
18. Minghetti, L., 2004. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain disease. J. Neuropathol. Exp. Neural., 6: 901-910.
19. Mladenovic, A., M. Perovic, N. Raicevic, S. Kanazir, L. Rakic and S. Ruzdijic 2004. 6-Hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats. Brain Res., 996: 237-245.
20. Murprogo, C., 1962. Effect of Antiparkinson Drug on a Phenothiazine Induced Catatonia Reaction. Arc. Int. Pharma. Co. Dyn., 137: 48-90.
21. Paxinos, G. and C. Watson 1997. The Rat Brain in Stereotaxic Coordinates. Academic Press. San Diego.
22. Rall, J.M., S.A. Mach and P.K. Dash, 2003. Intrahippocampal infusion cyclooxygenase-2 inhibitor attenuates memory acquisition in rats. Brain Res., 968: 273-276.
23. Riechman, W. and L.E. Hokin, 1987. Acetylcholine releases prostaglandins from brain slices incubated in vitro. J. Neurochem., 49: 1261-1221.
24. Sánchez-Pernaute, R., A. Ferree, O. Cooper, M Yu, A.L. Brownell and O. Isacson 2004. selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. J. Neuroinflammation, 1: 6
25. Shaftel, S.S., J.A. Olschowka and S.D. Hurly, 2003. COX-3: A splice variant of cyclooxygenase-1 in mouse neural tissue and cells. Brain Res., Mol. Brain Res., 119: 153-179.
26. Sharifzadeh, M., M. Tavasoli, N. Naghdi, A. Ghanbari, M. Amini and A. Roghani 2005. Post-training intrahippocampal infusion of nicotine prevents spatial memory retention deficits induced by the cyclooxygenase-2-specific inhibitor celecoxib in rats. J. Neurochem., 95: 1078-1090.
27. Smith, W.L., L.J. Marnett, D.L. Dewitt, 1991. Prostaglandin and thromboxane biosynthesis. Pharmacol. Ther., 49: 153-179.
28. Teismann, P. and B. Ferger, 2001. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease. Synapse, 39: 167-174.
29. Teismann, P., K. Tieu, D.K. Choi, D.C. Wu, A. Naini, S. Hunot, M. Vila, V. Jackson-Lewis and S. Przedborski, 2003. Cyclooxygenase-2 is instrument in Parkinson's Disease neurodegeneration. Proc. Natl. Acad. Sci. USA., 100: 5473-5478.
30. Wu, D.C., V. Jackson-Lewis, M. Vila, K. Tieu, P. Teismann, C. Vadseth, D.K. Choi, H. Ischiropoulos and S. Przedborski 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci., 22: 1763-1771.
31. Xie, W.L., G.J. Chipman, D.L. Robertson and R.L. Erikson, 1991. Expression of a mitogen responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA., 88: 2692-2696.
32. Yamagata, K., K.I. Andreasson, W.E. Kaufmann, C.A. Barnes and P.F. Worley 1993. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by Synaptic Activity and Glucocorticoids. Neuron, 11: 371-386.